Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keisuke Tada

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Annals of Hematology|April 21, 2025
Efficacy and safety of isatuximab monotherapy to treat relapsed or refractory multiple myeloma: a pooled analysis of clinical trialsMeletios Dimopoulos, Kazutaka Sunami, Xavier Leleu, et al.
Pediatric Surgery International|October 31, 2025
Portal hypertension in biliary atresia: a Japanese biliary atresia registry studyRyuji Okubo, Masaki Nio, Hideyuki Sasaki, et al.
Pediatric Surgery International|November 4, 2018
Treatment of classic-type Hirschsprung's disease: rectoplasty with posterior triangular colonic flap versus transanal endorectal pull-through with rectoanal myotomyMegumi Nakamura, Motoshi Wada, Taichi Fukuzawa, et al.
Cell Reports|June 29, 2024
BACH1 inhibits senescence, obesity, and short lifespan by ferroptotic FGF21 secretionHironari Nishizawa, Mitsuyo Matsumoto, Mie Yamanaka, et al.
Transplantation Proceedings|July 16, 2021
Intestinal Transplantation at a Single Institution in JapanHironori Kudo, Motoshi Wada, Hideyuki Sasaki, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 21, 2023
Isatuximab Plus Carfilzomib and Dexamethasone in East Asian Patients With Relapsed Multiple Myeloma: Updated IKEMA Subgroup AnalysisYawara Kawano, Kihyun Kim, Chang Ki Min, et al.
Blood Cancer Journal|November 28, 2024
Allocation and validation of the second revision of the International Staging System in the ICARIA-MM and IKEMA studiesPaul G Richardson, Aurore Perrot, Joseph Mikhael, et al.
Hematological Oncology|November 26, 2022
Anti-CD38 antibody isatuximab monotherapy for Japanese individuals with relapsed/refractory multiple myeloma: An update of the phase 1/2 ISLANDs studyKazutaka Sunami, Shin-Ichi Fuchida, Kenshi Suzuki, et al.
Cancer Science|September 25, 2020
Isatuximab monotherapy in relapsed/refractory multiple myeloma: A Japanese, multicenter, phase 1/2, safety and efficacy studyKazutaka Sunami, Kenshi Suzuki, Masaki Ri, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 31, 2022
Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup AnalysisKazutaka Sunami, Takashi Ikeda, Shang-Yi Huang, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Annals of Hematology|April 21, 2025
Efficacy and safety of isatuximab monotherapy to treat relapsed or refractory multiple myeloma: a pooled analysis of clinical trialsMeletios Dimopoulos, Kazutaka Sunami, Xavier Leleu, et al.
Pediatric Surgery International|October 31, 2025
Portal hypertension in biliary atresia: a Japanese biliary atresia registry studyRyuji Okubo, Masaki Nio, Hideyuki Sasaki, et al.
Pediatric Surgery International|November 4, 2018
Treatment of classic-type Hirschsprung's disease: rectoplasty with posterior triangular colonic flap versus transanal endorectal pull-through with rectoanal myotomyMegumi Nakamura, Motoshi Wada, Taichi Fukuzawa, et al.
Cell Reports|June 29, 2024
BACH1 inhibits senescence, obesity, and short lifespan by ferroptotic FGF21 secretionHironari Nishizawa, Mitsuyo Matsumoto, Mie Yamanaka, et al.
Transplantation Proceedings|July 16, 2021
Intestinal Transplantation at a Single Institution in JapanHironori Kudo, Motoshi Wada, Hideyuki Sasaki, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 21, 2023
Isatuximab Plus Carfilzomib and Dexamethasone in East Asian Patients With Relapsed Multiple Myeloma: Updated IKEMA Subgroup AnalysisYawara Kawano, Kihyun Kim, Chang Ki Min, et al.
Blood Cancer Journal|November 28, 2024
Allocation and validation of the second revision of the International Staging System in the ICARIA-MM and IKEMA studiesPaul G Richardson, Aurore Perrot, Joseph Mikhael, et al.
Hematological Oncology|November 26, 2022
Anti-CD38 antibody isatuximab monotherapy for Japanese individuals with relapsed/refractory multiple myeloma: An update of the phase 1/2 ISLANDs studyKazutaka Sunami, Shin-Ichi Fuchida, Kenshi Suzuki, et al.
Cancer Science|September 25, 2020
Isatuximab monotherapy in relapsed/refractory multiple myeloma: A Japanese, multicenter, phase 1/2, safety and efficacy studyKazutaka Sunami, Kenshi Suzuki, Masaki Ri, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 31, 2022
Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup AnalysisKazutaka Sunami, Takashi Ikeda, Shang-Yi Huang, et al.
Pageof 2